Results for tag: "Zotarolimus"

Zotarolimus is an immunosuppressive drug used to prevent organ rejection in transplant patients. It is a derivative of sirolimus, a macrolide antibiotic, and is a member of the rapamycin family of drugs. Zotarolimus works by inhibiting the activity of T-cells, which are responsible for the body's immune response. It is used in combination with other immunosuppressants, such as cyclosporine and tacrolimus, to reduce the risk of organ rejection. Zotarolimus is available in both oral and intravenous formulations. The market for Zotarolimus is highly competitive, with several major pharmaceutical companies offering the drug. Some of the companies in the market include Astellas Pharma, Novartis, Pfizer, and Merck. Show Less Read more